Abstract:Background Systemic lupus erythematosus (SLE) is an autoimmune disease with heterogeneous manifestations including severe organ damage and premature atherosclerosis. A mouse model of apolipoprotein E-deficient (apoE(-/-)) and Fas ligand-deficient (FasL(-/-)) showed accelerated atherosclerosis in lupus. Endothelial progenitor cells (EPCs) are a population of cells able to differentiate into endothelial cells and participating in the formation of blood vessels, its number and function play an important role in the development of atherosclerosis. Objectives To investigate the number and function of EPCs in Apoe-/-FasL-/- C57BL/6 mice, and to detect whether premature atherosclerosisof Apoe-/-FasL-/- C57BL/6 mice was mediated by dysfunction of these EPCs. Methods EPCs were isolated from peripherial blood, bone marrow and spleen of four types of C57BL/6 mice, ApoE+/+FasL+/+, ApoE+/+FasL-/-, ApoE-/-FasL+/+, ApoE-/-FasL-/-, growth and morphology changes of cultured and expanded EPCs from Bone marrow were observed under inverted microscope for 2 weeks. The percentage of EPCs was analyzed by FACS as CD11b-Sca-1+CD309+ cells. The attached cells were stained with Dil labeled acetylated low-density lipoprotein (Dil-ac-LDL) and FITC-labeled Ulex europaeus agglutinin 1(FITC-UEA-1) double dyeing to determine their swallow function. The adherent function of EPCs was determined by counting the number of recultured EPCs. The capacity of EPCs to form the cavity structure was detected by counting the number of formed vascular-like structure. Results The percentage of circulating EPCs was significantly decreased in ApoE-/-FasL-/- group (0.012% ± 0.008%) compared to ApoE+/+FasL+/+(0.034% ± 0.007%, P < 0.01), ApoE+/+FasL-/-(0.021% ± 0.002%, P<0.05), and ApoE-/-FasL+/+ group(0.018%±0.003%, P<0.05). The percentage of bone marrow derived EPCs was decreased in ApoE-/-FasL-/- group (0.12% ± 0.08%) compared to ApoE+/+FasL+/+(0.41% ± 0.11%, P < 0.05), ApoE+/+FasL-/-(0.17% ± 0.02%, P<0.05), and ApoE-/-FasL+/+ group(0.14%±0.03%, P<0.05). The weights of spleen and kidney of ApoE-/-FasL-/- mice were increased, while the percentage of spleen EPCs was significantly decreased (0.012%±0.003%, P<0.05). The percentage of Di-lac-LDL and FITC-UEA-1 double positive cells was decreased in ApoE-/-FasL-/- group (58% ±9%) compared to ApoE+/+FasL+/+(87%±10%, P< 0.05), ApoE+/+FasL-/-(82%±7%, P<0.05), and ApoE-/-FasL+/+ group(67%±7%, P<0.05). The adherent function of EPCs was decreased in ApoE-/-FasL-/- group (44%±8%) compared to ApoE+/+FasL+/+(82%±11%, P<0.01), ApoE+/+FasL-/-(72%±7%, P<0.05), and ApoE-/-FasL+/+ group(68%±3%, P<0.05). The capacity of EPCs to form the cavity structure was decreased in ApoE-/-FasL-/- group (4.0±0.8) compared to ApoE+/+FasL+/+(12.0±1.4, P<0.01), ApoE+/+FasL-/-(8.0±1.0, P<0.05), and ApoE-/-FasL+/+ group(6.5±1.2, P<0.05), respectively. Conclusions Premature atherosclerosisof Apoe-/-FasL-/- C57BL/6 mice was associated with decreased number and dysfunction of EPCs. Disclosure of Interest None Declared

IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus

Association Between Type I Interferon and Depletion and Dysfunction of Endothelial Progenitor Cells in C57BL/6 Mice Deficient in Both Apolipoprotein E and Fas Ligand.

Endothelial Cell Injury is Involved in Atherosclerosis and Lupus Symptoms in Gld.apoe- / - Mice.

Immunological pathogenesis and treatment of systemic lupus erythematosus

Long Non-Coding RNAs in Systemic Lupus Erythematosus: New Insights into Disease Pathogenesis and Diagnosis.

THU0537 Type I Interferon Induces Endothelial Progenitor Cell Dysfunction in Gld. Apoe-/- C57bl/6 Mice

Interferon-α Priming Promotes Lipid Uptake and Macrophage-Derived Foam Cell Formation: a Novel Link Between Interferon-Α and Atherosclerosis in Lupus.

The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus

AB0130 Premature Atherosclerosis of Apoe-/-fasl-/- C57bl/6 Mice Was Mediated by Dysfunction of Bone Marrow Derived Endothelial Progenitor Cells

Pathological mechanisms and crosstalk among various cell death pathways in cardiac involvement of systemic lupus erythematosus

Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus

Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis

Mesenchymal Stem Cell Transplantation Alleviated Atherosclerosis in Systemic Lupus Erythematosus Through Reducing MDSCs

Vascular damage in systemic lupus erythematosus

Systemic Lupus Erythematosus Aggravates Atherosclerosis by Promoting IgG Deposition and Inflammatory Cell Imbalance

Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus

TLR4+CXCR4+ Plasma Cells Drive Nephritis Development in Systemic Lupus Erythematosus

Study on the change of number and function of circulating endothelial progenitor cells in patients with active aystemic lupus erythematosus

Shedding of Endothelial Protein C Receptor Contributes to Vasculopathy and Renal Injury in Lupus: in Vivo and in Vitro Evidence

Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation